Dr. Steven Reremoser - Heelkunde
0500.706.377 · rovalta.com · 27/09/2026
Dr. Steven Reremoser - Heelkunde
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBODr. Steven Reremoser - Heelkunde is a Private limited company incorporated in 2012. Its registered office is in Antwerpen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0500.706.377
- Incorporation
- 09/11/2012
- Legal form
- Private limited company
- Registered office
- Koninklijkelaan 20
2600 Antwerpen · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 293,6 k € | +6.8% | 275 k € | +38.3% | 198,9 k € | +36.3% | 145,9 k € | -19.1% | 180,3 k € |
| EBITDA | 292 k € | +6.6% | 273,9 k € | +38.2% | 198,2 k € | +36.7% | 145 k € | -19.4% | 179,8 k € |
| Operating result | 279,2 k € | +7.8% | 259,1 k € | +41.0% | 183,7 k € | +125% | 81,6 k € | -31.0% | 118,3 k € |
| Net result | 225,2 k € | +10.8% | 203,1 k € | +43.2% | 141,9 k € | +135% | 60,3 k € | -30.4% | 86,6 k € |
| Balance sheet | |||||||||
| Equity | 572 k € | +17.0% | 489 k € | +35.2% | 361,7 k € | +28.4% | 281,7 k € | -18.1% | 343,7 k € |
| Total assets | 625,5 k € | +19.9% | 521,8 k € | +35.0% | 386,6 k € | +7.3% | 360,2 k € | -21.2% | 457 k € |
| Cash | 208 k € | +59.5% | 130,4 k € | +242% | 38,1 k € | +73.8% | 21,9 k € | -81.5% | 118,8 k € |
| Debts | 53,5 k € | +63.0% | 32,8 k € | +31.8% | 24,9 k € | -68.3% | 78,5 k € | -30.7% | 113,3 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Koninklijkelaan 20 2600 Antwerpen| Company | CBE no. |
|---|---|
Dr. Isabelle Meire, Gynaecologie● Active | 0834.052.421 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| General meeting | 12/06/2025 | 13/06/2024 | 08/06/2023 | 09/06/2022 | 10/06/2021 | 11/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 12/06/2025 | 30/09/2025 | Dutch | |
| Micro model | 31/12/2023 | 13/06/2024 | 30/09/2024 | Dutch | |
| Micro model | 31/12/2022 | 08/06/2023 | 30/09/2023 | Dutch | |
| Micro model | 31/12/2021 | 09/06/2022 | 30/09/2022 | Dutch | |
| Micro model | 31/12/2020 | 10/06/2021 | 30/09/2021 | Dutch | |
| Micro model | 31/12/2019 | 11/06/2020 | 30/09/2020 | Dutch | |
| Micro model | 31/12/2018 | 13/06/2019 | 30/09/2019 | Dutch | |
| Micro model | 31/12/2017 | 14/06/2018 | 31/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 31/05/2017 | 28/09/2017 | Dutch | |
| Abridged model | 31/12/2015 | 31/05/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 01/06/2015 | 30/09/2015 | Dutch | |
| Abridged model | 31/12/2013 | 31/05/2014 | 31/08/2014 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024225,2 k €↑
- 2023Annual accounts 2023203,1 k €↑
- 2022Annual accounts 2022141,9 k €↑
- 2021Annual accounts 202160,3 k €↓
- 2020Annual accounts 202086,6 k €↓
- 2019Annual accounts 2019105,6 k €↑
- 2018Annual accounts 201887,9 k €↑
- 2017Annual accounts 201773,6 k €↑
- 2016Annual accounts 201663,3 k €↑
- 2015Annual accounts 201548,1 k €↓
- 2014Annual accounts 201484,9 k €↓
- 2013Annual accounts 2013103,3 k €
- 09/11/2012IncorporationPrivate limited company